Elizabeth Olek

2011

In 2011, Elizabeth Olek earned a total compensation of $1.2M as Senior Vice President and Chief Medical Officer at Achillion Pharmaceuticals, a 54% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$99,056
Option Awards$837,548
Salary$288,500
Other$7,703
Total$1,232,807

Olek received $837.5K in option awards, accounting for 68% of the total pay in 2011.

Olek also received $99.1K in non-equity incentive plan, $288.5K in salary and $7.7K in other compensation.

Rankings

In 2011, Elizabeth Olek's compensation ranked 4,902nd out of 10,747 executives tracked by ExecPay. In other words, Olek earned more than 54.4% of executives.

ClassificationRankingPercentile
All
4,902
out of 10,747
54th
Division
Manufacturing
1,761
out of 3,960
56th
Major group
Chemicals And Allied Products
371
out of 1,038
64th
Industry group
Drugs
227
out of 786
71st
Industry
Pharmaceutical Preparations
177
out of 571
69th
Source: SEC filing on April 16, 2012.

Olek's colleagues

We found five more compensation records of executives who worked with Elizabeth Olek at Achillion Pharmaceuticals in 2011.

2011

Michael Kishbauch

Achillion Pharmaceuticals

Chief Executive Officer

2011

Milind Deshpande

Achillion Pharmaceuticals

Chief Executive Officer

2011

Joseph Truitt

Achillion Pharmaceuticals

Executive Vice President and Chief Commercial Officer

2011

Gautam Shah

Achillion Pharmaceuticals

Executive Vice President and Chief Compliance Officer

2011

Mary Fenton

Achillion Pharmaceuticals

Chief Financial Officer

In-depth

You may also like